CDK6 and cancer: Conversely, 11% of genes showed upregulation in cancer cell lines associated with oncogenic transformation, such as CDK6 (Log2 fold change of expression >1, adjusted p value < 0.05), as indicated by the differentiation markers upregulated by 71% in cancer lines.